80
Participants
Start Date
June 14, 2018
Primary Completion Date
November 14, 2019
Study Completion Date
August 13, 2020
Pegcetacoplan
Complement (C3) Inhibitor
Soliris
Complement (C5) Inhibitor
Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert
Royal Melbourne Hospital, Melbourne
AZ Delta Campus Wilgenstraat, Roeselare
New York Cancer & Blood Specialists, The Bronx
New York Cancer & Blood Specialists, East Setauket
Institut Paoli-Calmettes Marseille, Marseille
Roswell Park Cancer Institute, Buffalo
Soonchunhyang University Bucheon Hospital, Bucheon-si
Georgetown University Hospital, Washington D.C.
Universitätsklinikum Hamburg Eppendorf, Hamburg
Duke University Medical Center, Durham
Winship Cancer Institute of Emory University, Atlanta
Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse
Cancer Specialists of North Florida, Jacksonville
Mid Florida Hematology and Oncology, Orange City
Lakes Research, Miami Lakes
Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria
Chungnam National University Hospital, Daejeon
University of Tennessee Medical Center, Knoxville
Baptist Cancer Center, Memphis
Universitätsklinikum Essen, Essen
Hospital Universitario Politécnico La Fe, Valencia
Investigative Clinical Research of Indiana, Indianapolis
Cancer & Hematology Centers of Western Michigan, Grand Rapids
Uniklinik RWTH Aachen, Aachen
Centre Hospitalier Universitaire de Lille, Lille
Northwestern University, Chicago
Centre Hospitalier Lyon Sud, Pierre-Bénite
Centre Hospitalier William Morey, Chalon-sur-Saône
Centre Hospitalier Annecy Genevois, Annecy
Hôpital Saint-Louis, Paris
HOPE Cancer Center of East Texas, Tyler
Denver Health, Denver
Universitätsklinikum Ulm, Ulm
University of Southern California, Los Angeles
Sarcoma Oncology Research Center, Santa Monica
Good Samaritan Hospital, Corvallis
Pavlov First Saint Petersburg State Medical University of Russian Ministry of Health, Saint Petersburg
Pavlov First Saint Petersburg State Medical University, Saint Petersburg
Institution of Health Care of Tyumen Region, Tyumen
University of Alberta, Edmonton
Toronto General Hospital, Toronto
Centre Hospitalier de Saint-Quentin, Saint-Quentin
Japanese Red Cross Nagoya Daiichi Hospital, Nagoya
Japanese Red Cross Nagoya Daini Hospital, Showa-ku
University of Tsukuba Hospital, Tsukuba
Shinshu University Hospital, Matsumoto
Okayama University Hospital, Okayama
Juntendo University Hospital, Bunkyo-ku
NTT Medical Center Tokyo, Shinagawa-ku
Kinan Hospital, Tanabe
Samsung Medical Center, Seoul
St. James' Institute of Oncology, Leeds Teaching Hospitals, Leeds
Lead Sponsor
Apellis Pharmaceuticals, Inc.
INDUSTRY